Literature DB >> 6332753

Thyrogastric autoimmunity and MHC associated alleles at the C4 locus in patients with type 1 (insulin-dependent) diabetes.

V J McCann, J McCluskey, H Kelly, P H Kay, P J Zilko, F T Christiansen, R L Dawkins.   

Abstract

HLA antigens, complement allotypes, insulin antibodies and thyrogastric autoantibodies were determined in 69 patients with Type 1 (insulin-dependent) diabetes defined by a tendency to ketosis, non-obesity and insulin requirement within 2 years of diagnosis. Analysis of HLA and C4 allotypes suggested that Type 1 diabetes was associated with only certain DR3- and DR4-containing supratypes. Low antibody response to insulin was associated with all HLA-DR3, being present in 89% of those with DR3 compared with 48% of those without. Thyrogastric autoantibodies were associated with a null allele at the C4A locus, usually with HLA-B8-C4AQO-C4B1-BfS-DR3. These results indicate that, unlike Type 1 diabetes, low insulin antibody response was associated with all HLA-DR3. Thyrogastric autoantibodies, on the other hand, were associated with a null allele at the C4A locus. It is probable that while interaction between certain HLA-DR3 and DR4-containing supratypes is important in conferring susceptibility to Type 1 diabetes, other manifestations of autoimmunity are associated with supratypes containing C4AQ0, and in particular the diabetogenic supratype HLA-B8-C4AQ0-C4B1-BfS-DR3.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332753     DOI: 10.1007/bf00275667

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  6 in total

1.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Genetic marker for insulin-dependent diabetes mellitus.

Authors:  D Raum; C A Alper; R Stein; K H Gabbay
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

3.  HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.

Authors:  J McCluskey; V J McCann; P H Kay; P J Zilko; F T Christiansen; G J O'Neill; R L Dawkins
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

4.  Properdin factor B(Bf) allele BfF1 specifies an HLA-B18 diabetogenic haplotype.

Authors:  J Dornan; P Allan; E P Noel; B Larsen; N R Farid
Journal:  Diabetes       Date:  1980-06       Impact factor: 9.461

Review 5.  Type I diabetes mellitus.

Authors:  A G Cudworth
Journal:  Diabetologia       Date:  1978-05       Impact factor: 10.122

6.  Genetic polymorphism in human glycine-rich beta-glycoprotein.

Authors:  C A Alper; T Boenisch; L Watson
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.